Doximity Inc SEC Filings

Benjamin Regina M., a director of Doximity, Inc. (DOCS), received a grant of 3,221 restricted stock units (RSUs) on 08/28/2025 under the issuer's non-employee director compensation policy. Each RSU represents a contingent right to one share of Class A common stock and the grant was reported with a transaction price of $0. The RSUs vest in full on the earlier of the first anniversary of the grant date or the issuer's next annual meeting of stockholders, subject to the reporting person's continued service as a director through the applicable vesting date. After the grant, the reporting person beneficially owned 19,839 shares of Class A common stock on a direct basis. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 09/02/2025.

Kevin Spain, a director of Doximity, Inc. (DOCS), received 3,221 restricted stock units (RSUs) on 08/28/2025 as compensation under the company’s non-employee director policy. Each RSU converts to one share of Class A common stock and vests in full on the earlier of the first anniversary of the grant or the next annual meeting, subject to continued service. After the grant Mr. Spain directly beneficially owned 9,581 Class A shares, which includes 3,221 RSUs and 6,360 previously vested shares. He also has indirect holdings of 244,607 shares in The Kevin Spain Family Trust and 387,500 shares held by Emergence Capital Opportunity I, L.P., of which he is affiliated; he disclaims beneficial ownership of those indirect holdings except for any pecuniary interest.

Doximity, Inc. (DOCS) filing a Form 144 reports a proposed sale of 6,360 restricted common shares with an aggregate market value of $421,655.28, scheduled approximately for 09/02/2025 on the NYSE. The filing shows the shares were acquired as restricted stock on 08/28/2025 and lists total outstanding common shares of 187,299,459. The filer also disclosed sales during the past three months by Timothy Cabral: 20,000 shares sold on 08/15/2025 for $1,275,566.00 and 10,000 shares sold on 06/25/2025 for $600,000.00. Other customary Form 144 statements and signature cautions are included.

Doximity, Inc. (DOCS) Form 144 notice: An insider proposes to sell 2,000 common shares through Morgan Stanley Smith Barney on 09/02/2025 on the NYSE, with an aggregate market value of $133,140.00. The securities were acquired the same day via a stock option exercise and paid in cash. The filer previously sold 2,000 shares on 08/01/2025 for $114,180.00 and 2,000 shares on 07/01/2025 for $121,920.00. The filing includes the required representation that the seller does not possess undisclosed material adverse information.

Doximity CFO Anna Bryson reported transactions on 08/26/2025. The filing shows the Reporting Person acquired 40,000 shares of Class A common stock through conversion/exercise and simultaneously sold 40,000 shares pursuant to a Rule 10b5-1 trading plan adopted on 05/27/2025. The sales were executed at a weighted-average price of $66.7561 per share, with sale prices ranging from $66.2250 to $67.2200. Following these transactions the Reporting Person beneficially owns 346,925 shares (direct). The filing also discloses outstanding stock option activity related to 40,000 options with an $8.26 exercise price.

Insider transactions by Doximity director Timothy S. Cabral on 08/15/2025: Mr. Cabral converted 20,000 shares of Class B common stock into Class A shares and exercised 20,000 stock options with a $2.21 exercise price, resulting in 20,000 newly acquired Class A shares. He sold 16,200 Class A shares at a weighted-average price of approximately $63.682 and an additional 3,800 Class A shares at a weighted-average price of approximately $64.1889, under a Rule 10b5-1 trading plan adopted February 13, 2025. After these transactions he directly held 10,160 and 6,360 Class A shares as reported across sales; total Class B and exercised option conversions are noted as convertible to Class A.

Doximity, Inc. reporting person Anna Bryson, Chief Financial Officer, had 5,120 shares of Class A common stock withheld on 08/15/2025 to satisfy tax withholding related to the vesting of previously granted restricted stock units. The shares were withheld at a price of $63.54 per share and do not represent a discretionary sale by the reporting person; they were withheld pursuant to an election previously made by the issuer. After the withholding, the reporting person beneficially owns 346,925 shares of Class A common stock.

Jeffrey Tangney, Chief Executive Officer, Director and >10% owner of Doximity, Inc. (DOCS), reported a non‑discretionary reduction of 7,990 shares of Class A Common Stock on 08/15/2025. The shares were withheld by the issuer at a price of $63.54 per share to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units. This withholding was made pursuant to an issuer election and is not a voluntary sale by the reporting person. After the withholding, Mr. Tangney beneficially owned 2,249,058 shares of Class A Common Stock according to the Form 4 filing.